Ciara Kennedy is the founder of Aristea Therapeutics. Aristea Therapeutics has raised $78M in total funding. Latest round: Series B.
Ciara Kennedy, Ph.D. was appointed as an independent member of the Board of Directors at Aristea Therapeutics, a clinical-stage drug development company focused on novel therapies for serious inflammatory diseases. Prior to this role, Dr. Kennedy served as President and CEO of Amplyx Pharmaceuticals, Inc. and was COO of Lumena Pharmaceuticals, which was acquired by Shire Pharmaceuticals. She holds a doctorate from Queen's University of Belfast, Northern Ireland, and an MBA from the Rady School of Management at the University of California, San Diego.
Full founder directory · Investor directory · Company funding database · Fundraising library